spectral-ai-global-newswire.png
American Burn Association Study Highlights Inequities in Access to Specialized Burn Care
10 sept. 2024 08h00 HE | Spectral AI, Inc.
DALLAS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®
05 sept. 2024 08h00 HE | Spectral AI, Inc.
DALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI to Participate in Upcoming Investor Conferences
28 août 2024 16h30 HE | Spectral AI, Inc.
DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
27 août 2024 08h00 HE | Spectral AI, Inc.
DALLAS, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence
19 août 2024 08h00 HE | Spectral AI, Inc.
DALLAS, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Announces 2024 Second Quarter Financial Results
12 août 2024 16h05 HE | Spectral AI, Inc.
Second Quarter Revenue Totals $7.5 Million Total Enrollment Exceeds 85% for Burn Center Pivotal U.S. Clinical Trial Q2 2024 Overview Research & Development Revenue of $7.5 MillionCash...
spectral-ai-global-newswire.png
Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
31 juil. 2024 08h00 HE | Spectral AI, Inc.
DALLAS, July 31, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
29 juil. 2024 09h00 HE | Spectral AI, Inc.
DALLAS, July 29, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System
24 juil. 2024 08h00 HE | Spectral AI, Inc.
DALLAS, July 24, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...
spectral-ai-global-newswire.png
Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
23 juil. 2024 08h00 HE | Spectral AI, Inc.
DALLAS, July 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and...